Circulating tumor DNA measurement provides reliable mutation detection in mice with human lung cancer xenografts
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating tumor DNA measurement provides reliable mutation detection in mice with human lung cancer xenografts
Authors
Keywords
-
Journal
LABORATORY INVESTIGATION
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-03-02
DOI
10.1038/s41374-018-0041-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The feasibility of using mutation detection in ctDNA to assess tumor dynamics
- (2017) Xin Yi et al. INTERNATIONAL JOURNAL OF CANCER
- Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non–Small Cell Lung Cancer
- (2017) Suzanne Jenkins et al. Journal of Thoracic Oncology
- Quantitative cell-free circulating EGFR mutation concentration is correlated with tumor burden in advanced NSCLC patients
- (2017) Yan-juan Zhu et al. LUNG CANCER
- Plasma epidermal growth factor receptor mutation testing with a chip-based digital PCR system in patients with advanced non-small cell lung cancer
- (2017) Norimitsu Kasahara et al. LUNG CANCER
- Tumor volume determines the feasibility of cell-free DNA sequencing for mutation detection in non-small cell lung cancer
- (2016) Tatsuo Ohira et al. CANCER SCIENCE
- Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
- (2015) J. Tie et al. ANNALS OF ONCOLOGY
- Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer
- (2015) Kjersti Tjensvoll et al. Molecular Oncology
- Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis
- (2014) Dharanija Madhavan et al. BREAST CANCER RESEARCH AND TREATMENT
- Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
- (2014) T B Hao et al. BRITISH JOURNAL OF CANCER
- Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
- (2014) G. R. Oxnard et al. CLINICAL CANCER RESEARCH
- Serum Detection of Epidermal Growth Factor Receptor Gene Mutations Using Mutant-Enriched Sequencing in Chinese Patients with Advanced Non-Small Cell Lung Cancer
- (2013) B Jiang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Personalized medicine for lung cancer: new challenges for pathology
- (2011) Keith M Kerr HISTOPATHOLOGY
- Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus
- (2011) L. L. SWYSTUN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- High Fragmentation Characterizes Tumour-Derived Circulating DNA
- (2011) Florent Mouliere et al. PLoS One
- EGFRMutation Is a Better Predictor of Response to Tyrosine Kinase Inhibitors in Non–Small Cell Lung Carcinoma Than FISH, CISH, and Immunohistochemistry
- (2010) Lynette M. Sholl et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literature
- (2010) Klaus Jung et al. CLINICA CHIMICA ACTA
- Prevalence and Heterogeneity of KRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases
- (2010) S. E. Baldus et al. CLINICAL CANCER RESEARCH
- Targeted therapy in non-small-cell lung cancer—is it becoming a reality?
- (2010) Filip Janku et al. Nature Reviews Clinical Oncology
- Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
- (2010) Alain R. Thierry et al. NUCLEIC ACIDS RESEARCH
- EGFRand K-rasMutations Along the Spectrum of Pulmonary Epithelial Tumors of the Lung and Elaboration of a Combined Clinicopathologic and Molecular Scoring System to Predict Clinical Responsiveness to EGFR Inhibitors
- (2009) Giuliana Sartori et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Quantification of LINE1 in Circulating DNA as a Molecular Biomarker of Breast Cancer
- (2009) Eiji Sunami et al. Annals of the New York Academy of Sciences
- Epidermal Growth Factor Receptor Mutations in Plasma DNA Samples Predict Tumor Response in Chinese Patients With Stages IIIB to IV Non–Small-Cell Lung Cancer
- (2009) Hua Bai et al. JOURNAL OF CLINICAL ONCOLOGY
- Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
- (2009) Rafael Rosell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: A prognostic entity
- (2008) Jörg Ellinger et al. CANCER LETTERS
- Cell-Free Circulating DNA: Diagnostic Value in Patients With Testicular Germ Cell Cancer
- (2008) Jörg Ellinger et al. JOURNAL OF UROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started